These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27404213)

  • 21. Changes in vasopressin use and outcomes in surgical intensive care unit patients with septic shock.
    Lupei MI; Beilman GJ; Chipman JG; Mann HJ
    Chirurgia (Bucur); 2009; 104(5):575-81. PubMed ID: 19943557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Machine learning to predict vasopressin responsiveness in patients with septic shock.
    Scheibner A; Betthauser KD; Bewley AF; Juang P; Lizza B; Micek S; Lyons PG
    Pharmacotherapy; 2022 Jun; 42(6):460-471. PubMed ID: 35426141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Norepinephrine vs Vasopressin: Which Vasopressor Should Be Discontinued First in Septic Shock? A Meta-Analysis.
    Wu Z; Zhang S; Xu J; Xie J; Huang L; Huang Y; Yang Y; Qiu H
    Shock; 2020 Jan; 53(1):50-57. PubMed ID: 31008869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
    Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
    Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Vasopressin for Septic Shock in Patients on Chronic Renin-Angiotensin-Aldosterone System Inhibitors.
    Erwin BL; Denaburg MA; Barker AB; McArdle PJ; Windham ST; Morgan CJ
    Crit Care Med; 2017 Dec; 45(12):e1226-e1232. PubMed ID: 28991825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intractable hypotension in septic shock: successful treatment with vasopressin in an infant.
    Leibovitch L; Efrati O; Vardi A; Matok I; Barzilay Z; Paret G
    Isr Med Assoc J; 2003 Aug; 5(8):596-8. PubMed ID: 12929303
    [No Abstract]   [Full Text] [Related]  

  • 27. Predictors of Vasopressin Responsiveness in Critically Ill Adults.
    Allen B; Kram B; Kram S; Schultheis J; Wolf S; Gilstrap D; Shapiro M
    Ann Pharmacother; 2018 Feb; 52(2):126-132. PubMed ID: 28853293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II and Vasopressin for Vasodilatory Shock: A Critical Appraisal of Catecholamine-Sparing Strategies.
    Heavner MS; McCurdy MT; Mazzeffi MA; Galvagno SM; Tanaka KA; Chow JH
    J Intensive Care Med; 2021 Jun; 36(6):635-645. PubMed ID: 32223515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock.
    Menich BE; Miano TA; Patel GP; Hammond DA
    Ann Pharmacother; 2019 Sep; 53(9):877-885. PubMed ID: 30957512
    [No Abstract]   [Full Text] [Related]  

  • 30. The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial.
    Gordon AC; Mason AJ; Perkins GD; Stotz M; Terblanche M; Ashby D; Brett SJ
    Crit Care Med; 2014 Jun; 42(6):1325-33. PubMed ID: 24557425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant vasopressin and hydrocortisone therapy on short-term hemodynamic effects and vasopressor requirements in refractory septic shock.
    Buckley MS; MacLaren R
    J Crit Care; 2017 Dec; 42():6-11. PubMed ID: 28647651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial.
    Hajjar LA; Zambolim C; Belletti A; de Almeida JP; Gordon AC; Oliveira G; Park CHL; Fukushima JT; Rizk SI; Szeles TF; Dos Santos Neto NC; Filho RK; Galas FRBG; Landoni G
    Crit Care Med; 2019 Dec; 47(12):1743-1750. PubMed ID: 31609774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of vasopressin on acute kidney injury in septic shock.
    Gordon AC; Russell JA; Walley KR; Singer J; Ayers D; Storms MM; Holmes CL; Hébert PC; Cooper DJ; Mehta S; Granton JT; Cook DJ; Presneill JJ
    Intensive Care Med; 2010 Jan; 36(1):83-91. PubMed ID: 19841897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-Line Vasopressor Use in Septic Shock and Route of Administration: An Epidemiologic Study.
    Teja B; Bosch NA; Wijeysundera DN; Wijeysundera HC; Saskin R; Hill AD; Stelfox HT; Walkey AJ; Wunsch H
    Ann Am Thorac Soc; 2022 Oct; 19(10):1713-1721. PubMed ID: 35709214
    [No Abstract]   [Full Text] [Related]  

  • 35. Mortality, Morbidity, and Costs After Implementation of a Vasopressin Guideline in Medical Intensive Care Patients With Septic Shock: An Interrupted Time Series Analysis.
    Bauer SR; Sacha GL; Reddy AJ
    Ann Pharmacother; 2020 Apr; 54(4):314-321. PubMed ID: 31679395
    [No Abstract]   [Full Text] [Related]  

  • 36. Combination of norepinephrine with phenylephrine versus norepinephrine with vasopressin in critically ill patients with septic shock: A retrospective study.
    Arishi H; AlQahtani S; Tamim H; Sadat M; Alenezi FZ; Bin Humaid F; AlWehaibi W; Arabi YM
    J Crit Care; 2022 Dec; 72():154121. PubMed ID: 35908329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does body weight impact the efficacy of vasopressin therapy in the management of septic shock?
    Miller JT; Welage LS; Kraft MD; Alaniz C
    J Crit Care; 2012 Jun; 27(3):289-93. PubMed ID: 21855282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock.
    Hodge EK; Hughes DW; Attridge RL
    Ann Pharmacother; 2016 Oct; 50(10):816-23. PubMed ID: 27340145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practice Patterns and Outcomes Associated With Choice of Initial Vasopressor Therapy for Septic Shock.
    Fawzy A; Evans SR; Walkey AJ
    Crit Care Med; 2015 Oct; 43(10):2141-6. PubMed ID: 26079345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of vasopressin in vasodilatory septic shock.
    Obritsch MD; Bestul DJ; Jung R; Fish DN; MacLaren R
    Pharmacotherapy; 2004 Aug; 24(8):1050-63. PubMed ID: 15338853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.